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background: Acute myocardial infarction (AMI) is responsible for a substantial and growing burden of death and disability in China. However, there 
is little information on trends of patient characteristics, treatment, and patient outcomes.
methods: We collected a nationally representative sample of patients with AMI during 2001, 2006, and 2011 using a two-stage random sampling 
design within economic-geographic regions. Data were collected via standardized chart review. Multivariable models were constructed to calculate 
adjusted in-hospital mortality.
results: We identified 16,100 AMI admissions from 162 hospitals. The median age was 65 years in 2001, 67 years in 2006, and 66 years in 2011. 
Patients were more likely to be current smokers and have hypertension, diabetes, or dyslipidemia over time. By 2011, 24% had at least three risk 
factors. The trends of treatment, length of stay, and in-hospital mortality are shown in Table. After adjusting for patient characteristics, the risk of 
mortality significantly decreased over time.
Conclusions: Over the past decade in China, patients with AMI had more comorbidity, more treatment with primary percutaneous coronary 
intervention but no greater overall reperfusion treatment for ST-segment elevation myocardial infarction, shorter length of stay, and lower in-hospital 
mortality. Despite favorable changes in care substantial opportunities to improve AMI care remain.
Table:
2001
n=2299
2006
n=4468
2011
n=9333
p value
Age, y, 65(56,72) 67(56,74) 66(56,75) <0.01
Female sex, % 30 30 32 <0.05
Reperfusion Therapies, %
No reperfusion 45 47 45 0.08
Primary PCI 10 17 28 <0.01
Fibrinolytic therapy 45 36 27 <0.01
Acute medications, %
Aspirin≤ 24 h 78 87 90 <0.01
Clopidogrel ≤ 24 h 1 47 81 <0.01
β-blockers ≤ 24 h 48 61 55 <0.05
Statins during hospitalization 30 75 92 <0.01
Angiotensin converting enzyme inhibitors/ angiotensin receptor blocker 61 70 66 <0.01
Traditional Chinese Medicine ≤ 24 h 45 49 56 <0.01
Length of stay, d 12(7,18) 10(6,15) 10(6,14) <0.01
Mortality, crude, % 8.4 9.6 6.6 <0.01
Adjusted mortality†, OR (95% CI) ref 0.96(0.73,1.27) 0.77(0.58,1.03)
